GranaGard Nano-Omega 5 Scientific Studies
About the research
Granalix aims to provide its customers with products based on science and natural ingredients. The company’s labs are run by Prof. Ruth Gabizon from Hadassah Medical Center and Prof. Shlomo Magdassi from the Hebrew University. The company’s laboratories conduct research on various models to assess the safety and effects of the company’s products. These studies have been published in leading scientific journals following thorough peer review.
Relevant studies on the company’s products are also implemented in clinical trials with humans, in close collaboration with the neurology departments at Hadassah Hospital and Ichilov Hospital, as well as the neuropsychology department at Rambam Hospital and a research institute in Mexico.
2023
Latest studies
12% improvement in cognitive abilities.
The trial in humans was conducted at Hadassah Ein Kerem University Hospital in Jerusalem, by Prof. Dimitrius Karussis, an international renowned neurologist, along with Dr. Panayiota Petrou. The trial was approved by the Helsinki Committee for Clinical Trials in Humans.
It was found that in people who received GranaGard for just 3 months, exhibited a 12% improvement in the CVLT-II test which measures cognitive memory abilities.
All studies
September 2021
12% improvement in cognitive abilities
Beneficial effects of a nano formulation of pomegranate seed oil, GranaGard, on the cognitive function of multiple sclerosis patients
P. Petrou MD, A. Ginzberg PhD., O. Binyamin PhD. and D. Karussis MD, PhD.
April 2022
GranaGard and recovery from head trauma
Nano-PSO Administration Attenuates Cognitive and Neuronal Deficits Resulting from Traumatic Brain Injury
D Qubty, K Frid, M Har-Even, V Rubovitch, R Gabizon
February 2022
GranaGard and anti-aging
Comparing anti–aging hallmark activities of Metformin and Nano-PSO in a mouse model of genetic Creutzfeldt-Jakob Disease
O Binyamin, K Frid, G Keller, A Saada, R Gabizon
September 2020
Accelerated breakdown of fatty acids in the liver
Punica granatum L.-derived omega-5 nanoemulsion improves hepatic steatosis in mice fed a high fat diet by increasing fatty acid utilization in hepatocytes
K. Zamora-López, L. G. Noriega, A. Estanes-Hernández, I. Escalona-Nández, S. Tobón-Cornejo, A. R. Tovar, V. Barbero-Becerra & C. Pérez-Monter
December 2019
GranaGard affects cognition
Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice
O Binyamin, K Nitzan, K Frid, Y Ungar, H Rosenmann, R Gabizon
April 2019
GranaGard and free radicals
Mitochondrial dysfunction in preclinical genetic prion disease: A target for
preventive treatment?
G Keller, O Binyamin, K Frid, A Saada, R Gabizon
August 2017
GranaGard and life span
Continues administration of Nano-PSO significantly increased survival of genetic CJD mice
Binyamin O, Keller G, Frid K, Larush L, Magdassi S, Gabizon R.
November 2015
GranaGard and anti-inflammatory activity
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant
Binyamin O, Larush L, Frid K, Keller G, Friedman-Levi Y, Ovadia H, Abramsky O, Magdassi S, Gabizon R